FDA Inspection
VitalantVitalant – FDA Inspection, Nov 1, 2011
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on November 1, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- November 1, 2011
- Product Type
- Biologics
View Company Profile
ID · 926404f5-bfbc-420d-b260-15f8abc351d8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 752456
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 640.31Donor eligibility
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 31, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 6, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 30, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1238350 - 2024-04-25
- FDA Inspection 1075128 - 2018-10-31
- FDA Inspection 998083 - 2016-12-06
- FDA Inspection 913381 - 2015-02-06
- FDA Inspection 856431 - 2013-10-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.